Article Correctness Is Author's Responsibility: Cedars-Sinai Awarded $11.99 Million for ALS Clinical Trial

The article below may contain offensive and/or incorrect content.

This shows DNACedars-Sinai has been awarded $11.99 million by California's stem cell agency to launch a clinical trial testing a potential gene and stem cell therapy for amyotrophic lateral sclerosis (ALS).